TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11842880

Group type: EXPERIMENTAL
Intervention: 300mg S-PS daily
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 600mg S-PS daily
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 9543974

Group type: EXPERIMENTAL
Intervention: Combine dressing pad
Number of subjects: 36

Group type: COMPARATOR
Intervention: Calcium alginate
Number of subjects: 36

Group type: COMPARATOR
Intervention: Sodium hypochlorite (0.05%)
Number of subjects: 36
Study: 8067557

Group type: EXPERIMENTAL
Intervention: eltanolone
Number of subjects: 60

Group type: COMPARATOR
Intervention: propofol
Number of subjects: 60
Study: 3141755

Group type: EXPERIMENTAL
Intervention: Glibenclamide (three times a day)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 31663412

Group type: EXPERIMENTAL
Intervention: Vignette addressing individual as 'suffering from substance use disorder'
Number of subjects: 184

Group type: COMPARATOR
Intervention: Vignette addressing individual as an 'addict'
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Gender (Women)
Number of subjects: 184
Study: 29056601

Group type: EXPERIMENTAL
Intervention: Semi‐automated volume measurements
Number of subjects: 2240

Group type: COMPARATOR
Intervention: Mean axial diameter
Number of subjects: 2240

Group type: COMPARATOR
Intervention: Maximum axial diameter
Number of subjects: 2240
Study: 28208006

Group type: EXPERIMENTAL
Intervention: EUS‐FNB
Number of subjects: 58

Group type: COMPARATOR
Intervention: EUS‐FNA
Number of subjects: 58
Study: 25742205

Group type: EXPERIMENTAL
Intervention: Acamprosate (1,998 mg/d orally)
Number of subjects: 327

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 327
Study: 23108604

Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.4 mg/tadalafil 5 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Tamsulosin 0.4 mg/placebo
Number of subjects: 40
Study: 21677574

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg/d
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 18297270

Group type: EXPERIMENTAL
Intervention: CAM‐ICU assessments by bedside nurses
Number of subjects: 1011

Group type: EXPERIMENTAL
Intervention: CAM‐ICU assessments by bedside nurses in TBI patients
Number of subjects: 1011

Group type: EXPERIMENTAL
Intervention: CAM‐ICU assessments by bedside nurses in mechanically ventilated patients
Number of subjects: 1011

Group type: EXPERIMENTAL
Intervention: Post-implementation survey of nurses
Number of subjects: 1011
Study: 16539548

Group type: EXPERIMENTAL
Intervention: Mind map
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Acronym
Number of subjects: 30

Group type: COMPARATOR
Intervention: Information leaflet
Number of subjects: 30
Study: 14737726

Group type: EXPERIMENTAL
Intervention: Radioiodine therapy with (131)I at doses ranging from 5‐200 mCi
Number of subjects: 0
Study: 16227794

Group type: COMPARATOR
Intervention: Nevirapine (NVP) administered to mothers at labor onset and to infants within 72 hours of birth.
Number of subjects: 1491

Group type: COMPARATOR
Intervention: Nevirapine (NVP) administered to infants < 4 hours after birth.
Number of subjects: 1491

Group type: COMPARATOR
Intervention: Nevirapine (NVP) administered to mothers within 24 hours of delivery.
Number of subjects: 1491

Group type: COMPARATOR
Intervention: Nevirapine (NVP) administered to infants within 48 hours after delivery.
Number of subjects: 1491
Study: 10352203

Group type: EXPERIMENTAL
Intervention: 2 L exchange volume
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 2.5 L exchange volume
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 3 L exchange volume
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Peritoneal clearances of creatinine
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Peritoneal clearances of urea nitrogen
Number of subjects: 20
Study: 9012296

Group type: EXPERIMENTAL
Intervention: 3xED95 cisatracurium
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: 5xED95 cisatracurium
Number of subjects: 62

Group type: COMPARATOR
Intervention: 3xED90 vecuronium
Number of subjects: 62
Study: 2045027

Group type: EXPERIMENTAL
Intervention: Automatic visual acuity test using an LCD screen with 400 x 640 pixel display of Landolt rings.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Testing of visual acuity at short time intervals.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Delegation of the test to support personnel.
Number of subjects: 0
Study: 7272706

Group type: EXPERIMENTAL
Intervention: Cryotherapy
Number of subjects: 42

Group type: COMPARATOR
Intervention: Electrocautery
Number of subjects: 42
Study: 30462199

Group type: EXPERIMENTAL
Intervention: MR using Gene‐by‐Environment interactions (MRGxE)
Number of subjects: 0
Study: 27984024

Group type: EXPERIMENTAL
Intervention: Povidone-iodine 1.25% ophthalmic solution
Number of subjects: 172

Group type: COMPARATOR
Intervention: Topical antibiotics (neomycin-polymyxin B-gramicidin in the Philippines; ciprofloxacin 0.3% in India)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Topical antibiotics
Number of subjects: 172
Study: 25471330

Group type: EXPERIMENTAL
Intervention: Ranibizumab 0.3 mg plus single standard verteporfin PDT
Number of subjects: 40

Group type: COMPARATOR
Intervention: Ranibizumab 0.3 mg plus sham PDT
Number of subjects: 40
Study: 25125237

Group type: EXPERIMENTAL
Intervention: Video featuring a pediatric transplant recipient (with or without sound)
Number of subjects: 781

Group type: EXPERIMENTAL
Intervention: All six videos (including the pediatric transplant recipient video)
Number of subjects: 781

Group type: EXPERIMENTAL
Intervention: Minority race
Number of subjects: 781

Group type: EXPERIMENTAL
Intervention: Positive change in organ donor readiness
Number of subjects: 781

Group type: EXPERIMENTAL
Intervention: Total positive emotion
Number of subjects: 781
Study: 22621716

Group type: EXPERIMENTAL
Intervention: CT scan intervention group (n = 2,052)
Number of subjects: 4104

Group type: COMPARATOR
Intervention: Control group (n = 2,052)
Number of subjects: 4104
Study: 19805698

Group type: EXPERIMENTAL
Intervention: Telephone care management intervention (up to 5 outreach calls for monitoring and support)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Care management plus telephone psychotherapy intervention (8-session structured cognitive behavioral therapy program with up to 4 additional calls)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 600
Study: 17173213

Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine gluconate washes and 2% mupirocin ointment intranasally, with oral rifampin and doxycycline for 7 days
Number of subjects: 146

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Decolonization therapy
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Mupirocin-resistant isolate at baseline
Number of subjects: 146
Study: 14998805

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 11486310

Group type: EXPERIMENTAL
Intervention: High-dose therapy (HDT) supported with autologous stem cells
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Melphalan 200 mg/m(2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Unpurged peripheral blood stem cells (PBSC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tandem transplants
Number of subjects: 0
Study: 9706915

Group type: EXPERIMENTAL
Intervention: Propofol (2 mg x kg(‐1) x h(‐1))
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Sufentanil (0.25 microg x kg(‐1) x h(‐1) with bolus midazolam 2 mg)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Midazolam (0.07‐0.15 microg x kg(‐1) x h(‐1))
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 36
Study: 8311209

Group type: EXPERIMENTAL
Intervention: Entonox
Number of subjects: 40

Group type: COMPARATOR
Intervention: Epidural analgesia
Number of subjects: 40
Study: 30843421

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) for 16 weeks
Number of subjects: 54

Group type: COMPARATOR
Intervention: Sham acupuncture for 16 weeks
Number of subjects: 54
Study: 28193574

Group type: EXPERIMENTAL
Intervention: Preterm SGA
Number of subjects: 2510

Group type: COMPARATOR
Intervention: Term AGA
Number of subjects: 2510

Group type: EXPERIMENTAL
Intervention: Preterm AGA
Number of subjects: 2510

Group type: EXPERIMENTAL
Intervention: Term SGA
Number of subjects: 2510
Study: 26437606

Group type: EXPERIMENTAL
Intervention: Blastocyst stage transfer (BS group, n = 57)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Cleavage stage transfer (CS group, n = 61)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Blastocyst stage transfer (BS group)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Cleavage stage transfer (CS group)
Number of subjects: 118
Study: 22957771

Group type: EXPERIMENTAL
Intervention: Contact lens-based pinhole
Number of subjects: 22

Group type: COMPARATOR
Intervention: PureVision Multifocal contact lenses
Number of subjects: 22
Study: 21950196

Group type: EXPERIMENTAL
Intervention: Melatonin (20 mg/day) for 12 weeks
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Melatonin (20 mg/day)
Number of subjects: 13
Study: 18490892

Group type: EXPERIMENTAL
Intervention: Early onset rehabilitation program (15 sessions of individual rehabilitation)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Home exercise program (self-performed exercises after drain removal)
Number of subjects: 57
Study: 16521172

Group type: EXPERIMENTAL
Intervention: Sump-type tube on continuous suction drainage
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Single-lumen tube with free drainage and 4-hourly aspiration
Number of subjects: 34

Group type: COMPARATOR
Intervention: No NG tube
Number of subjects: 34
Study: 12664121

Group type: EXPERIMENTAL
Intervention: Iodixanol
Number of subjects: 100

Group type: COMPARATOR
Intervention: Iopromide
Number of subjects: 100
Study: 10630440

Group type: EXPERIMENTAL
Intervention: Oral rehydration solution plus Lactobacillus GG (at least 10(10) CFU/250 ml)
Number of subjects: 287

Group type: COMPARATOR
Intervention: Oral rehydration solution plus placebo
Number of subjects: 287
Study: 8704460

Group type: EXPERIMENTAL
Intervention: Pre-admission education programme
Number of subjects: 40

Group type: COMPARATOR
Intervention: Information from ward staff on admission
Number of subjects: 40
Study: 1531487

Group type: EXPERIMENTAL
Intervention: Manual therapy
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Physiotherapy
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Treatment by general practitioner (GP)
Number of subjects: 256

Group type: COMPARATOR
Intervention: Placebo therapy (detuned ultrasound and detuned short wave diathermy)
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 256
Study: 3079991

Group type: EXPERIMENTAL
Intervention: Oxygen‐permeable polyurethane dressing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oxygen‐nonpermeable hydrocolloid dressing
Number of subjects: 0
Study: 29691617

Group type: EXPERIMENTAL
Intervention: Surgical treatment for Achilles tendon rupture
Number of subjects: 100

Group type: COMPARATOR
Intervention: Non-surgical treatment for Achilles tendon rupture
Number of subjects: 100
Study: 27879147

Group type: EXPERIMENTAL
Intervention: Novel agent induction regimens (including proteasome inhibitors (PIs) and immunomodulatory drugs (IMiDs)) prior to HDM/SCT
Number of subjects: 45

Group type: COMPARATOR
Intervention: No novel agent induction regimens prior to HDM/SCT
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Novel agent induction regimens (including PIs and IMiDs) prior to HDM/SCT
Number of subjects: 45
Study: 24939677

Group type: EXPERIMENTAL
Intervention: Infliximab ≤3 mg/kg
Number of subjects: 462

Group type: EXPERIMENTAL
Intervention: Infliximab 3-5 mg/kg
Number of subjects: 462

Group type: EXPERIMENTAL
Intervention: Infliximab ≥5 mg/kg
Number of subjects: 462

Group type: EXPERIMENTAL
Intervention: Infliximab (all doses)
Number of subjects: 462
Study: 23126252

Group type: EXPERIMENTAL
Intervention: Dalcetrapib (600 mg daily)
Number of subjects: 15871

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15871

Group type: EXPERIMENTAL
Intervention: Dalcetrapib
Number of subjects: 15871
Study: 20483049

Group type: EXPERIMENTAL
Intervention: Infliximab (3 mg/kg) administered at week 0, 2, 6, and 14 along with stable dose of methotrexate
Number of subjects: 20

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 20
Study: 18283230

Group type: EXPERIMENTAL
Intervention: Electrical stimulation of the quadriceps (15 patients)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Usual physiotherapy alone (11 patients)
Number of subjects: 26
Study: 15768049

Group type: EXPERIMENTAL
Intervention: BDNF val66met genotype (val/val homozygotes, N=27)
Number of subjects: 44

Group type: COMPARATOR
Intervention: BDNF val66met genotype
Number of subjects: 44
Study: 12466380

Group type: EXPERIMENTAL
Intervention: Pegvisomant (1 mg/kg sc)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 10513498

Group type: EXPERIMENTAL
Intervention: Spouse-assisted coping skills training (CST)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Conventional CST (no spouse involvement)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Spouse-assisted CST
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Spouse-assisted CST and Conventional CST
Number of subjects: 88

Group type: COMPARATOR
Intervention: Conventional CST and AE-SS control
Number of subjects: 88
Study: 7796154

Group type: EXPERIMENTAL
Intervention: Caffeine 200 mg administered at 07.10 h
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Caffeine 200 mg
Number of subjects: 9
Study: 1710673

Group type: EXPERIMENTAL
Intervention: Low-dose chemotherapy with central nervous system prophylaxis and zidovudine maintenance
Number of subjects: 42
Study: 6115732

Group type: EXPERIMENTAL
Intervention: 10 mg propranolol
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 40 mg propranolol
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 200 mg sotalol
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 31403867

Group type: EXPERIMENTAL
Intervention: Toripalimab (1 or 3 mg/kg via intravenous infusion every 2 weeks) + Axitinib (5 mg orally twice a day)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Toripalimab + Axitinib
Number of subjects: 33
Study: 28602137

Group type: EXPERIMENTAL
Intervention: Phototherapy (Group 1 - 2.62 J)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Phototherapy (Group 2 - 5.24 J)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Phototherapy (Group 3 - 7.86 J)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 60
Study: 27768192

Group type: EXPERIMENTAL
Intervention: Remote care group using new tools for 6 months: remote and self-monitoring, self-adjustment of device, and a personalized online support tool
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group following the standard care pathway
Number of subjects: 60
Study: 24718019

Group type: EXPERIMENTAL
Intervention: Simulated communication training course
Number of subjects: 0

Group type: COMPARATOR
Intervention: Case-based communication training course
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study: 22912552

Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum 299v (DSM 9843)
Number of subjects: 214

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 214
Study: 19918967

Group type: EXPERIMENTAL
Intervention: Apilimod mesylate 50 mg daily
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Apilimod mesylate 100 mg daily
Number of subjects: 220

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 220
Study: 18853350

Group type: EXPERIMENTAL
Intervention: Greater positive partner support to quit smoking
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: Minority status
Number of subjects: 333
Study: 15647885

Group type: EXPERIMENTAL
Intervention: Effective intravaginal electrical stimulation (IES)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham intravaginal electrical stimulation (IES)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups (G1 and G2)
Number of subjects: 40
Study: 12824968

Group type: EXPERIMENTAL
Intervention: Immediate colposcopy
Number of subjects: 1572

Group type: EXPERIMENTAL
Intervention: HPV triage
Number of subjects: 1572

Group type: EXPERIMENTAL
Intervention: Conservative management (repeat cytology at HSIL threshold)
Number of subjects: 1572

Group type: EXPERIMENTAL
Intervention: Lower cytology thresholds
Number of subjects: 1572
Study: 10397121

Group type: EXPERIMENTAL
Intervention: IV glucagon (1 mg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Nonglucagon (control)
Number of subjects: 60
Study: 8893686

Group type: EXPERIMENTAL
Intervention: Peritoneal fluid from women with moderate or severe endometriosis
Number of subjects: 30

Group type: COMPARATOR
Intervention: Peritoneal fluid from women with fertile women without endometriosis
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Percoll‐purified sperm fractions with peritoneal fluid from women with moderate or severe endometriosis
Number of subjects: 30
Study: 1725004

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 21

Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 21
Study: 6151789

Group type: EXPERIMENTAL
Intervention: Low-frequency transcutaneous nerve stimulation (TNS) at 2 Hz for 30-45 min
Number of subjects: 21
Study: 30482055

Group type: EXPERIMENTAL
Intervention: KiSS treatment (multicomponent six-session program including CBT-I, hypnotherapy, and imaginations)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 45
Study: 31178421

Group type: EXPERIMENTAL
Intervention: Inhaled 7% hypertonic saline nebulised twice daily for 48 weeks
Number of subjects: 150

Group type: COMPARATOR
Intervention: 0.9% isotonic saline nebulised twice daily for 48 weeks
Number of subjects: 150
Study: 29328838

Group type: EXPERIMENTAL
Intervention: Amiodarone 3mg/kg intravenously over 20 minutes prior to skin incision
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Dronedarone 400mg orally twice daily, commencing three days prior to surgery
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Dronedarone
Number of subjects: 36
Study: 25357187

Group type: EXPERIMENTAL
Intervention: Thread-traction method (TT method)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional ESD (group C)
Number of subjects: 40
Study: 24005882

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) (808 nm; 100 mW; 35.7 W/cm(2), 357.14 J/cm(2) per point, energy of 1 J per point applied for 10 s on four points of the biceps brachii belly of each arm)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT)
Number of subjects: 22
Study: 23007025

Group type: EXPERIMENTAL
Intervention: Biocompatible PD solution (Balance®, Fresenius; LS)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Conventional PD solution (CAPD/DPCA®, Fresenius; CS)
Number of subjects: 63
Study: 19064125

Group type: EXPERIMENTAL
Intervention: Hypocaloric diet Type I (WT group)
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Hypocaloric diet Type II (WT group)
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Hypocaloric diet Type I (mutant group)
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Hypocaloric diet Type II (mutant group)
Number of subjects: 203
Study: 17855735

Group type: EXPERIMENTAL
Intervention: Epidural mepivacaine (0.15 ml kg(‐1) bolus of 2% mepivacaine, followed by 0.1 ml kg(‐1) h(‐1))
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Neostigmine (0.04 mg kg(‐1) at 25% recovery of the first twitch of TOF)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no epidural mepivacaine)
Number of subjects: 80
Study: 15196516

Group type: EXPERIMENTAL
Intervention: Handrail usage
Number of subjects: 30

Group type: COMPARATOR
Intervention: Older adults
Number of subjects: 30

Group type: COMPARATOR
Intervention: Walking velocity
Number of subjects: 30
Study: 10753985

Group type: EXPERIMENTAL
Intervention: Intraventricular urokinase treatment
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 9816086

Group type: EXPERIMENTAL
Intervention: IFN‐gamma at dose levels ranging from 0.01 to 0.90 mg/m2, administered as a 1‐h i.v. infusion three times per week for at least 8 weeks or until progressive disease.
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: IFN‐gamma
Number of subjects: 98
Study: 1466326

Group type: EXPERIMENTAL
Intervention: Physical training at home for 8 weeks
Number of subjects: 25
Study: 6547461

Group type: EXPERIMENTAL
Intervention: Double-blind, placebo-controlled food challenges
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Prick skin tests (STs)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: RAST
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Combination of STs and RASTs
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Skin testing
Number of subjects: 40
Study: 30611598

Group type: EXPERIMENTAL
Intervention: Comprehensive oral management protocol including spacers, pilocarpine hydrochloride, and topical dexamethasone ointment for oral mucositis
Number of subjects: 124

Group type: COMPARATOR
Intervention: Control group receiving only oral care
Number of subjects: 124
Study: 30428863

Group type: EXPERIMENTAL
Intervention: Usual care with supervised foot-ankle exercises (twice a week for 12 weeks) and remotely supervised exercises for a year
Number of subjects: 77

Group type: COMPARATOR
Intervention: Usual care (control arm)
Number of subjects: 77
Study: 26525162

Group type: EXPERIMENTAL
Intervention: IMR(s)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: IMR(c)
Number of subjects: 48
Study: 22525130

Group type: EXPERIMENTAL
Intervention: Nile Red stain
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Oil Red O stain
Number of subjects: 8

Group type: COMPARATOR
Intervention: Negative control lenses
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Human-worn lotrafilcon A lenses
Number of subjects: 8
Study: 20935397

Group type: EXPERIMENTAL
Intervention: Oral montelukast (10 mg/day)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Oral doxophylline (400 mg/day)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Inhaled budesonide (400 mcg)
Number of subjects: 50

Group type: COMPARATOR
Intervention: All groups (A, B, C)
Number of subjects: 50